case 3:03-cv-03709-si document 414 filed 09/05/2006 page 1...

53
ATTORNEYS AT LAW SILICON VALLEY CASE NO. C-03-3709-SI(EMC) DECLARATION OF LUI-KWAN ISO OPPOSITION TO REQUEST TO ALTER PROTECTIVE ORDER 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 LATHAM & WATKINS LLP Paul H. Dawes (Bar No. 55191) John C. Tang (Bar No. 212371) Michele D. Johnson (Bar No. 198298) Kalama M. Lui-Kwan (Bar No. 242121) Peter T. Snow (Bar No. 222117) 140 Scott Drive Menlo Park, California 94025 Telephone: (650) 328-4600 Facsimile: (650) 463-2600 Counsel for CV Therapeutics, Inc. and the Individual Defendants UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN FRANCISCO DIVISION IN RE CV THERAPEUTICS, INC. SECURITIES LITIGATION This Document Relates To: All Actions Master File No. C-03-3709-SI(EMC) CLASS ACTION DECLARATION OF KALAMA M. LUI-KWAN IN SUPPORT OF DEFENDANTS’ OPPOSITION TO PLAINTIFF’S FIFTH REQUEST TO ALTER PROTECTIVE ORDER Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 of 4

Upload: others

Post on 23-May-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel

ATTORNEYS AT LAW

SILI CON VALLEY

CASE NO. C-03-3709-SI(EMC) DECLARATION OF LUI-KWAN ISO OPPOSITION TO REQUEST TO ALTER PROTECTIVE ORDER

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

LATHAM & WATKINS LLP Paul H. Dawes (Bar No. 55191) John C. Tang (Bar No. 212371) Michele D. Johnson (Bar No. 198298) Kalama M. Lui-Kwan (Bar No. 242121) Peter T. Snow (Bar No. 222117) 140 Scott Drive Menlo Park, California 94025 Telephone: (650) 328-4600 Facsimile: (650) 463-2600 Counsel for CV Therapeutics, Inc. and the Individual Defendants

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

SAN FRANCISCO DIVISION

IN RE CV THERAPEUTICS, INC. SECURITIES LITIGATION This Document Relates To: All Actions

Master File No. C-03-3709-SI(EMC) CLASS ACTION DECLARATION OF KALAMA M. LUI-KWAN IN SUPPORT OF DEFENDANTS’ OPPOSITION TO PLAINTIFF’S FIFTH REQUEST TO ALTER PROTECTIVE ORDER

Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 of 4

Page 2: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel

ATTORNEYS AT LAW

SILI CON VALLEY

CASE NO. C-03-3709-SI(EMC) DECLARATION OF LUI-KWAN ISO OPPOSITION TO REQUEST TO ALTER PROTECTIVE ORDER

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

I, Kalama M. Lui-Kwan, declare as follows:

1. I am an attorney with Latham & Watkins LLP (“Latham”), counsel for defendants

CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel K. Spiegelman (“Defendants”). I

make this declaration in support of Defendants’ Opposition to Plaintiff’s Fifth Request to Alter

Protective Order. The facts set forth herein are within my personal knowledge.

Correspondence Regarding Plaintiff’s First Request

2. On August 16, 2006, Plaintiff sent Defendants a letter requesting approval to

disclose certain documents to two experts, Shalini Gera and Zoë Beh (“August 16, 2006

Request”). Attached to the August 16, 2006 Request are a list of documents Plaintiff requested

approval to disclose to his experts, and two biographies of Mss. Gera and Beh. Attached as

Exhibit 1 is a true and correct copy of Plaintiff’s August 16, 2006 Request.

3. On August 17, 2006, Defendants sent a letter to Plaintiff requesting information

required by ¶¶ 7.4(a)(2)-(5) of the February 7, 2005 Protective Order (“August 17, 2006 Letter”).

Attached as Exhibit 2 is a true and correct copy of Defendants’ August 17, 2006 Letter.

4. On August 18, 2006, Plaintiff sent Defendants a letter responding to the August

17, 2006 Letter (“August 18, 2006 Letter”). Attached as Exhibit 3 is a true and correct copy of

Plaintiff’s August 18, 2006 Letter.

5. On August 21, 2006, Defendants sent Plaintiff a letter responding to the August

18, 2006 Letter (“August 21, 2006 Letter”). Attached as Exhibit 4 is a true and correct copy of

Defendants’ August 21, 2006 Letter.

6. On August 25, 2006, Defendants sent Plaintiff a letter objecting to the August 16,

2006 Request (“August 25, 2006 Objections”). Attached as Exhibit 5 is a true and correct copy

of Defendants’ August 25, 2006 Objections.

7. On August 28, 2006, Plaintiff sent Defendants a letter responding to the August

25, 2006 Objections (“Plaintiff’s August 28, 2006 Letter”). Attached as Exhibit 6 is a true and

correct copy of Plaintiff’s August 28, 2006 Letter.

8. On August 28, 2006, Defendants sent Plaintiff a letter responding to the August

Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 2 of 4

Page 3: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel

ATTORNEYS AT LAW

SILI CON VALLEY

CASE NO. C-03-3709-SI(EMC) DECLARATION OF LUI-KWAN ISO OPPOSITION TO REQUEST TO ALTER PROTECTIVE ORDER

2

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

28, 2006 Letter (“Defendants’ August 28, 2006 Letter”). Attached as Exhibit 7 is a true and

correct copy of Defendants’ August 28, 2006 Letter.

Plaintiff’s Second and Third Requests

9. On August 25, 2006, Plaintiff sent Defendants a letter requesting approval to

disclose certain documents to one expert, James Cunha (“August 25, 2006 Request”). Attached

to the August 25, 2006 Request are a list of documents Plaintiff requested approval to disclose to

his expert, and Mr. Cunha’s resumé. Attached as Exhibit 8 is a true and correct copy of

Plaintiff’s August 25, 2006 Request.

10. On August 28, 2006, Plaintiff sent Defendants a letter requesting approval to

disclose certain documents to one expert, Bjorn Steinholt (“August 28, 2006 Request”).

Attached to the August 28, 2006 Request are a list of documents Plaintiff requested approval to

disclose to his expert, Mr. Steinholt’s resumé, and a Declaration of Bjorn I. Steinholt. Attached

as Exhibit 9 is a true and correct copy of Plaintiff’s August 28, 2006 Request.

Defendants’ Document Productions

11. Defendants have made six significant document productions in this litigation and

delivered most of the documents at issue in productions more than a year ago. I prepared the

table below, which identifies the (1) date of each production, (2) ending bates number of each

production, and (3) number of documents in each production that Plaintiff now seeks approval to

disclose.

Production Date Ending Bates Number Number of Documents Plaintiff Seeks to Disclose

February 7, 2005 CVT 00442896 5 March 1, 2005 CVT 00529301 23

August 25, 2005 CVT 00856395 2 March 1, 2006 CVT 01532749 0 April 25, 2006 CVT 01836258 4 June 29, 2006 CVT 02411627 1

CVT’s Press Release

12. Upon information and belief, on January 27, 2006, CVT issued a press release

entitled “FDA Approves Ranexa” (“January 27, 2006 Press Release”). Attached as Exhibit 10 is

a true and correct copy of CVT’s January 27, 2006 Press Release.

Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 3 of 4

Page 4: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel

ATTORNEYS AT LAW

SILI CON VALLEY

CASE NO. C-03-3709-SI(EMC) DECLARATION OF LUI-KWAN ISO OPPOSITION TO REQUEST TO ALTER PROTECTIVE ORDER

3

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

I declare under penalty of perjury under the laws of the State of California and the United

States of America that the foregoing is true and correct and that this declaration was executed on

September 5, 2006 at Menlo Park, California.

/S/ Kalama M. Lui-Kwan

SV\521804.1

Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 4 of 4

Page 5: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 6: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 7: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 8: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 9: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 10: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 11: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 12: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 13: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 14: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 15: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 16: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 17: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 18: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 19: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 20: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 21: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 22: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 23: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 24: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 25: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 26: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 27: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 28: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 29: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 30: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 31: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 32: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 33: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 34: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 35: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 36: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 37: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 38: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 39: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 40: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 41: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 42: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 43: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 44: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 45: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 46: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 47: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 48: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 49: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 50: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 51: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 52: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel
Page 53: Case 3:03-cv-03709-SI Document 414 Filed 09/05/2006 Page 1 ...securities.stanford.edu/.../CVTX03-01/...033709.pdf · CV Therapeutics, Inc. (“CVT”), Louis G. Lange, and Daniel